Cargando…
MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial
BACKGROUND: Traumatic brain injury (TBI) is a significant cause of death and disability, with no effective neuroprotective drugs currently available for its treatment. Mesenchymal stromal cell (MSC)-based therapy shows promise as MSCs release various soluble factors that can enhance the injury micro...
Autores principales: | Zanier, Elisa R., Pischiutta, Francesca, Rulli, Eliana, Vargiolu, Alessia, Elli, Francesca, Gritti, Paolo, Gaipa, Giuseppe, Belotti, Daniela, Basso, Gianpaolo, Zoerle, Tommaso, Stocchetti, Nino, Citerio, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449745/ https://www.ncbi.nlm.nih.gov/pubmed/37620640 http://dx.doi.org/10.1186/s40635-023-00535-1 |
Ejemplares similares
-
Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
por: Carbonara, Marco, et al.
Publicado: (2018) -
Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury
por: Pischiutta, Francesca, et al.
Publicado: (2021) -
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice
por: Sammali, Eliana, et al.
Publicado: (2017) -
International prospective observational study on intracranial pressure in intensive care (ICU): the SYNAPSE-ICU study protocol
por: Citerio, Giuseppe, et al.
Publicado: (2019) -
Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
por: Zoerle, Tommaso, et al.
Publicado: (2017)